Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
GA²LEN Global Asthma & Allergy Excellence Network
Gemeinnützige Organisationen
Berlin, Berlin 1.928 Follower:innen
GA²LEN was founded in 2005, unites researchers to improve collaboration and excellence in allergy and asthma research.
Info
GA²LEN, the Global Allergy and Asthma European Network, is a consortium of leading European research centres specialized in allergic diseases, which include asthma. Funded by the European Union under the 6th Framework Programme, GA²LEN addresses the growing public health concern of allergic diseases. UCARE With over 172 member centres in 47 countries, GA²LEN’s network of urticaria centres of reference and excellence (UCARE) is the biggest and most active global consortium of urticariologists and urticaria centres. The aim of the UCARE network is to improve the management of urticaria, a common, debilitating, and often hard to treat condition that can be challenging for both patients and treating physicians, especially when chronic. The main aims of GA²LEN UCARE are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. ACARE The angioedema centers of reference and excellence (ACARE) program is a joint initiative by GA²LEN and HAE International (HAEi) for developing and accrediting an interactive network of centers of reference and excellence in angioedema. Angioedema is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when recurrent. The main aims of the GA²LEN | HAEi ACARE program and network is to provide excellence in angioedema management, increase the knowledge of angioedema by research and education, promote the awareness of angioedema by advocacy activities. We aim to broaden access to modern HAE medicines in countries where they are available and to make concerted and systematic efforts to bring modern medicines to countries where there are none.
- Website
-
https://globalga2len.network/
Externer Link zu GA²LEN Global Asthma & Allergy Excellence Network
- Branche
- Gemeinnützige Organisationen
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin, Berlin
- Art
- Nonprofit
- Spezialgebiete
- Urticaria Management, Angioedema Management, Patient Education, Physician Education, Networking, Webinars und Educational Events
Orte
-
Primär
Wegbeschreibung
Berlin, Berlin, DE
Beschäftigte von GA²LEN Global Asthma & Allergy Excellence Network
Updates
-
We would be delighted if you could join us on this special day and keep the memory of Marcus Maurer alive. ♥ Please let us know by December, 31 whether we can count on your participation by registering here: https://shorturl.at/bod15 IFA Website: https://lnkd.in/dNuc5z8p
-
-
Join our upcoming webinar featuring a distinguished faculty of experts: Prof. Dr. Doctora Anna Gimenez Arnau (UCARE at Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain) Dr. Murat Türk (Division of Allergy and Clinical Immunology, Erciyes University, Kayseri, Türkiye) Prof. Dr. Emek Kocatürk Göncü (Charité - Universitätsmedizin Berlin; Fraunhofer IMP, Berlin, Germany) Prof. Dr. Martin Metz (Charité - Universitätsmedizin Berlin; Fraunhofer IMP, Berlin, Germany) 📅 Don’t miss this opportunity to learn from leading experts in the field. 🔗 Register here: https://lnkd.in/dg_NC-At #Webinar #MedicalEducation #UCARE #AllergyAndImmunology #levelup #urticaria #cu
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Exciting news! Sophia Neisinger, MD, is featured on the cover of Deutsche Dermatologie! Published by the German Professional Association of Dermatologists (BVDD), this journal is considered a must-read for dermatologists. We are thrilled about this recognition and proud to collaborate with you, dear Sophia. Congratulations on this well deserved achievement! 🎉👏 #Dermatology #DeutscheDermatologie #BVDD #Congratulations
🎉 Da ist es! 🎉 Unsere Mitgründerin Sophia Neisinger, MD ist auf dem Cover der Deutschen Dermatologie! Herausgegeben vom Berufsverband der Deutschen Dermatologen e.V (BVDD) ist die Zeitschrift die „Pflichtlektüre“ für Dermatologinnen und Dermatologen. Wir freuen uns sehr mit Sophia darin prominent vertreten zu sein. 🚀 Besonders schön für uns als kleines Weihnachtsgeschenk, da wir aktuell an neuen Indikationen im Bereich Dermatologie (und darüber hinaus) arbeiten. Schönen Donnerstag! 😊
-
-
We're excited to announce that CRUSE® has officially launched in Chile and Bulgaria! 🌍 This brings our app to an incredible 37 countries worldwide, supporting even more people in managing Chronic Urticaria. Thank you for being part of our growing global community! 💚 #CRUSEApp #ChronicUrticaria #GlobalLaunch #healthcareapp #ucare #crusecontrol #urticaria #hives
-
-
The UCARE LevelUp (ULU) Program is back for its third round in 2025! This global initiative by GA²LEN’s Urticaria Centers of Reference and Excellence (UCARE) continues to empower physicians worldwide with the knowledge and tools to improve care for urticaria patients. 📅 Next Webinar (No. 12): Solar Urticaria: Diagnosis and Management for Physicians 🗓️ Date: Thursday, February 27th, 2025 🕑 Time: 2:00 – 3:00 PM Register link: https://lnkd.in/dn9MTzj7 Join us as we kick off the 2025 webinar series, providing cutting-edge insights into differential diagnoses, research, and treatment options for urticaria. 📩 For questions, contact Rebekka Locke at rebekka.locke@ga2len.network #UCARELevelUp #ULUProgram #Urticaria #MedicalEducation #GlobalCare"
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Join us for the next ACARE Make A Difference webinar series as we dive deeper into advancing care for recurrent angioedema and hereditary angioedema (HAE). 📅 Upcoming Webinar: HAE in Children 🗓️ Date: January 9th, 2025 🕔 Time: 5:00 - 6:00 PM CET Let’s explore strategies for early diagnosis, family screening, and therapy optimization to make a lasting impact. Don’t miss this opportunity to enhance patient outcomes! 👉 Register now and make a difference: https://lnkd.in/dN3Xn-v7 Speakers: Thomas Buttgereit, Grzegorz Porebski, Henriette Farkas, Emel Aygören-Pürsün #HAE #Angioedema #WebinarSeries #MedicalEducation #MakeADifference
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Chronic Urticaria affects millions worldwide, but with the CRUSE® App, managing your condition has never been easier. 🌍 ✨ We're thrilled to see CRUSE® making a global impact, helping more and more people take control of their symptoms every day. 💪 Download now and join the growing community of users improving their quality of life with CRUSE®! 📲 https://cruse-control.com/ #ChronicUrticaria #HealthApp #TakeControl #crusecontrol #ucare #hives
-
GA²LEN Global Asthma & Allergy Excellence Network hat dies direkt geteilt
Medical Doctor @Charité I Digital Health & Dermatology | Top 25 Future Maker I Newcomer Entrepreneur of the Year 🚀
🤍 The Global Urticaria Forum and Urticaria Guideline Consensus Conference was filled with incredible insights, thought-provoking discussions, and, for many of us, moments of reflection and tears as we remembered Prof. Marcus Maurer. 🌟 Talks that left a lasting impression: > Dr. Stefan Frischbutter's presentation on the role of eosinophils in chronic spontaneous urticaria. > Dr. Pavel Kolkhir's talk on mortality in chronic spontaneous urticaria (CSU). While CSU itself doesn’t directly cause death, ... his findings will be published soon. > Prof. Michihidro Hide's talk during the Advent symposium, where we learned that it takes an average of 2 years and 6 doctors for a chronic urticaria diagnosis! 🙏 So honored to have received a (and my first) poster prize. Thanks a lot to the scientific committee Emek Kocatürk Doctora Anna Gimenez Arnau Torsten Zuberbier LUIS FELIPE ENSINA. And congrats to the other winners, from our team a.o. Geraldine Gerdel Matute! 🇮🇳 See you December 2025 in India for the UCARE conference hosted by Prof.Dr.Kiran Godse MD PhD FRCP(Glasg)!
-
-
-
-
-
+2
-
-
Prof. Dr. Marcus Maurer (1966–2024) was an exceptional scientist, teacher, and clinician whose groundbreaking work transformed the treatment of urticaria and angioedema. His legacy continues to shape the field of allergy research and improve patient care worldwide. We are grateful to Prof. Werner Aberer for this heartfelt tribute, now published in SKIN (Issue 04/2024, November). The full article is available to read here: https://lnkd.in/dVFp8-UN. Thank you, Werner, for honoring Marcus Maurer’s immense contributions and keeping his inspiring motto alive: “Never give up!”
-